Summary: A newly developed drug, Vorasidenib, has shown promise in prolonging progression-free survival for patients with a subtype of glioma. The international study found that patients taking Vora… [+8451 chars]Read More
Targeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors Neuroscience News
